Human monoclonal antibodies derived from B cells of patients infected from the early SARS-CoV-2 variants and from vaccinated individuals are rapidly losing their efficacy with the emergence of new ...

With the help of artificial intelligence, an international team of researchers has made the first major inroad to date toward ...

Antibodies have been identified that neutralize Omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.

The breakthrough could be used in a new vaccine or antibody therapy to fight mpox, the disease caused by the monkeypox virus.

ST. LOUIS — Antibodies generated by Pfizer’s COVID-19 vaccine are effective at blocking the delta variant – more so than at least one other variant – according to a new study from researchers at ...

(RTTNews) - Immunome Inc. (IMNM) said that its three-antibody cocktail (IMM-BCP-01) has neutralized the SARS-CoV-2 Delta variant in pre-clinical pseudovirus testing. In Tuesday pre-market trading, ...

Scientists are exploring every possible option when it comes to the development of COVID-19 treatments. A potential therapeutic could be found in Single-domain Variable New Antigen Receptors (VNARs) ...

Researchers used AI to pinpoint a previously overlooked mpox surface protein that human antibodies strongly target. When ...

Viral variation has proved to be a critical weak point in our approach to medical solutions for controlling Covid-19. Over the last two and a half years, we've seen successive waves of reinfection by ...